GLP-1 medications are generally not recommended for people with severe gastrointestinal disease, such as severe gastroparesis
Back Manalac, T (23 Dec 2024) '7 Indications for GLP-1s beyond weight loss', BioSpace
PSYCHIATRIC ADVERSE EFFECTS Evidence based on recent studies While GLP-1 RAs have demonstrated potent glucose-lowering effects, their impact on diabetic retinopathy remains incompletely elucidated
Manufacturing capacity, regulatory requirements and market demand are important factors that may impact this timeline
One year after Lund and Goodman made their unexpected finding, another team successfully isolated and sequenced the pancreatic preproglucagon from a hamster islet library
One According to a The 2016 review mentioned earlier reported several other findings: Rodent studies have shown that an olive oil-enriched diet increased GLP-1 secretion, glucose-stimulated insulin secretion, and glucose tolerance